Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00541970
What this trial is testing

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 961
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797894
What this trial is testing

Safety and Immunogenicity of HPV Vaccine in HIV-infected

Who this might be right for
HIV-infected Individuals
Beijing 302 Hospital 80
Post-approval studies (Phase 4)UnknownNCT04270773
What this trial is testing

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women

Who this might be right for
HIV InfectionsHPV Infection
University Hospital Virgen de las Nieves 158
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Large-scale testing (Phase 3)Active Not RecruitingNCT06465914
What this trial is testing

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Who this might be right for
Genital WartPenile CancerAnal Cancer+7 more
Shanghai Bovax Biotechnology Co., Ltd. 9,000
Large-scale testing (Phase 3)Study completedNCT01456715
What this trial is testing

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Who this might be right for
Human Papillomavirus
Laval University 418
Large-scale testing (Phase 3)Study completedNCT01277042
What this trial is testing

Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,212
Large-scale testing (Phase 3)Study completedNCT02576054
What this trial is testing

Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 101
Large-scale testing (Phase 3)Study completedNCT05372016
What this trial is testing

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Testing effectiveness (Phase 2)Study completedNCT05496231
What this trial is testing

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Who this might be right for
Cervical Intraepithelial Neoplasia
GlaxoSmithKline 1,080
Large-scale testing (Phase 3)Active Not RecruitingNCT05285826
What this trial is testing

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 8,100
Large-scale testing (Phase 3)Study completedNCT01627561
What this trial is testing

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 148
Testing effectiveness (Phase 2)Study completedNCT05694728
What this trial is testing

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc 780
Testing effectiveness (Phase 2)Study completedNCT00316693
What this trial is testing

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,046
Testing effectiveness (Phase 2)Study completedNCT04436133
What this trial is testing

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

Who this might be right for
HPV InfectionHPV-Related Cervical Carcinoma
National Vaccine and Serum Institute, China 480
Large-scale testing (Phase 3)Not Yet RecruitingNCT07785843
What this trial is testing

A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 930
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Large-scale testing (Phase 3)Study completedNCT00157950
What this trial is testing

Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 176
Large-scale testing (Phase 3)Study completedNCT01381575
What this trial is testing

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,447
Next Page